FDA Inspection 1201113 — SURGENEX LLC
The FDA completed an inspection of SURGENEX LLC on March 29, 2023 in Scottsdale, AZ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). 1 citation was issued during this inspection. Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 29, 2023
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Scottsdale, AZ (United States)
Citations
| ID | CFR | Description |
|---|---|---|
| 12390 | 21 CFR 1271.220(c) | In-process HCT/Ps-control |